Strs Ohio Has $1.15 Million Holdings in Cerner Co. (NASDAQ:CERN)

Strs Ohio raised its position in Cerner Co. (NASDAQ:CERN) by 39.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,751 shares of the company’s stock after buying an additional 4,462 shares during the period. Strs Ohio’s holdings in Cerner were worth $1,154,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Hartford Investment Management Co. lifted its position in shares of Cerner by 0.3% during the second quarter. Hartford Investment Management Co. now owns 104,219 shares of the company’s stock worth $7,639,000 after purchasing an additional 313 shares in the last quarter. Mn Services Vermogensbeheer B.V. lifted its position in shares of Cerner by 212.7% during the second quarter. Mn Services Vermogensbeheer B.V. now owns 166,127 shares of the company’s stock worth $12,177,000 after purchasing an additional 113,000 shares in the last quarter. Notis McConarty Edward acquired a new position in shares of Cerner during the second quarter worth approximately $220,000. Daiwa Securities Group Inc. lifted its position in shares of Cerner by 6.7% during the second quarter. Daiwa Securities Group Inc. now owns 12,827 shares of the company’s stock worth $940,000 after purchasing an additional 800 shares in the last quarter. Finally, Quadrant Capital Group LLC lifted its position in shares of Cerner by 42.1% during the second quarter. Quadrant Capital Group LLC now owns 2,810 shares of the company’s stock worth $200,000 after purchasing an additional 833 shares in the last quarter. Hedge funds and other institutional investors own 82.59% of the company’s stock.

In other Cerner news, CAO Michael R. Battaglioli sold 10,468 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $69.09, for a total value of $723,234.12. Following the completion of the sale, the chief accounting officer now owns 8,226 shares of the company’s stock, valued at $568,334.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Randy D. Sims sold 48,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $69.27, for a total transaction of $3,324,960.00. The disclosure for this sale can be found here. Insiders sold 441,468 shares of company stock valued at $30,777,997 in the last ninety days. Insiders own 0.75% of the company’s stock.

CERN opened at $70.88 on Wednesday. Cerner Co. has a fifty-two week low of $48.78 and a fifty-two week high of $76.47. The company has a debt-to-equity ratio of 0.22, a quick ratio of 2.50 and a current ratio of 2.52. The company has a market capitalization of $22.74 billion, a P/E ratio of 32.07, a price-to-earnings-growth ratio of 2.04 and a beta of 0.92. The business’s 50 day simple moving average is $73.05.

Cerner (NASDAQ:CERN) last issued its earnings results on Wednesday, July 24th. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.58 by $0.02. Cerner had a net margin of 10.75% and a return on equity of 15.14%. The firm had revenue of $1.43 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm earned $0.62 earnings per share. The business’s quarterly revenue was up 4.6% on a year-over-year basis. As a group, equities analysts anticipate that Cerner Co. will post 2.43 earnings per share for the current fiscal year.

The company also recently announced a special dividend, which was paid on Friday, July 26th. Shareholders of record on Tuesday, June 18th were paid a $0.18 dividend. The ex-dividend date was Monday, June 17th. Cerner’s payout ratio is presently 32.58%.

A number of research firms recently weighed in on CERN. Wells Fargo & Co boosted their price target on shares of Cerner from $72.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 25th. Piper Jaffray Companies boosted their price target on shares of Cerner from $74.00 to $80.00 and gave the stock an “overweight” rating in a research note on Thursday, July 25th. BidaskClub downgraded shares of Cerner from a “hold” rating to a “sell” rating in a research note on Thursday, July 25th. Cantor Fitzgerald boosted their price target on shares of Cerner from $75.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, July 8th. Finally, Zacks Investment Research downgraded shares of Cerner from a “buy” rating to a “hold” rating and set a $77.00 price target for the company. in a research note on Monday, July 29th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and eleven have issued a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $73.36.

About Cerner

Cerner Corporation provides health care information technology solutions and tech-enabled services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.

See Also: What is a capital gains distribution?

Want to see what other hedge funds are holding CERN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cerner Co. (NASDAQ:CERN).

Institutional Ownership by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.